scispace - formally typeset
S

Shuki Mizutani

Researcher at Tokyo Medical and Dental University

Publications -  220
Citations -  7872

Shuki Mizutani is an academic researcher from Tokyo Medical and Dental University. The author has contributed to research in topics: Leukemia & Hematopoietic stem cell transplantation. The author has an hindex of 44, co-authored 217 publications receiving 7300 citations.

Papers
More filters
Journal ArticleDOI

Clinical course of patients with WASP gene mutations

TL;DR: It is demonstrated that WAS protein expression is a useful tool for predicting long-term prognosis for patients with WAS/XLT and hematopoietic stem cell transplantation should be considered, especially for WASP-negative patients, while the patients are young to improve prognosis.
Journal Article

Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion.

TL;DR: The data suggest that specific chemical exposures of the fetus during pregnancy may cause MLL gene fusions, and the widespread use of dipyrone, Baygon, and other carbamate-based insecticides in certain settings is urgently required.
Journal ArticleDOI

Chk2 Activation Dependence on Nbs1 after DNA Damage

TL;DR: It is shown that the ATM-dependent activation of Chk2 by γ- radiation requires Nbs1, the gene product involved in the Nijmegen breakage syndrome (NBS), a disorder that shares with AT a variety of phenotypic defects including chromosome fragility, radiosensitivity, and radioresistant DNA synthesis, and suggest that checkpoint defects in NBS cells may result from the inability to activate Chk1.
Journal ArticleDOI

Identification of a gene expression signature associated with pediatric AML prognosis

TL;DR: The results indicate the existence of prognosis-associated genes that are independent of cell lineage and cytogenetic abnormalities, and they can provide therapeutic direction for individual risk-adapted therapy for pediatric AML patients.